Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (511-520 of 933) with videos related to

Pageof 94
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 23, 2018
Can clinicopathological parameters predict for lymph node metastases in ypT0-2 rectal carcinoma? Results of the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 phase 3 trialsJens Müller von den Grün, Arndt Hartmann, Rainer Fietkau, et al.
European Urology|July 19, 2018
Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated RecommendationsZachary Klaassen, Ashish M Kamat, Wassim Kassouf, et al.
The American Journal of Pathology|October 15, 2013
IFN-γ-driven intratumoral microenvironment exhibits superior prognostic effect compared with an IFN-α-driven microenvironment in patients with colon carcinomaSandra Grenz, Elisabeth Naschberger, Susanne Merkel, et al.
The American Journal of Surgical Pathology|September 10, 2020
Langerhans Cell Histiocytosis Associated With Renal Cell Carcinoma Is a Neoplastic Process: Clinicopathologic and Molecular Study of 7 CasesAbbas Agaimy, Michael Bonert, Asghar Naqvi, et al.
The Oncologist|July 12, 2019
Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2)Ricarda Merten, Oliver Ott, Marlen Haderlein, et al.
Gut|June 25, 2014
IL-9 and its receptor are predominantly involved in the pathogenesis of UCNancy Nalleweg, Mircea Teodor Chiriac, Eva Podstawa, et al.
Journal of Crohn'S & Colitis|December 26, 2025
Intestinal Barrier healing is superior to transmural healing to prevent disease progession in clinical remittent patients with IBDTill Orlemann, Dana Zimmermann, Hannah Hübner, et al.
Nature Communications|February 19, 2026
HIF sustain a transcriptional regulatory circuit of EPAS1 expression in renal clear cell carcinomaStephanie Naas, René Krüger, Steffen Grampp, et al.
The Journal of Pathology|October 1, 2003
WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancerChristoph Wissmann, Peter Johannes Wild, Simone Kaiser, et al.
Cancer Research|December 4, 2002
Frequent microsatellite instability in sporadic tumors of the upper urinary tractArndt Hartmann, Livia Zanardo, Tina Bocker-Edmonston, et al.
Pageof 94

Showing results (511-520 of 933) with videos related to

Sort By:
Pageof 94
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 23, 2018
Can clinicopathological parameters predict for lymph node metastases in ypT0-2 rectal carcinoma? Results of the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 phase 3 trialsJens Müller von den Grün, Arndt Hartmann, Rainer Fietkau, et al.
European Urology|July 19, 2018
Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated RecommendationsZachary Klaassen, Ashish M Kamat, Wassim Kassouf, et al.
The American Journal of Pathology|October 15, 2013
IFN-γ-driven intratumoral microenvironment exhibits superior prognostic effect compared with an IFN-α-driven microenvironment in patients with colon carcinomaSandra Grenz, Elisabeth Naschberger, Susanne Merkel, et al.
The American Journal of Surgical Pathology|September 10, 2020
Langerhans Cell Histiocytosis Associated With Renal Cell Carcinoma Is a Neoplastic Process: Clinicopathologic and Molecular Study of 7 CasesAbbas Agaimy, Michael Bonert, Asghar Naqvi, et al.
The Oncologist|July 12, 2019
Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2)Ricarda Merten, Oliver Ott, Marlen Haderlein, et al.
Gut|June 25, 2014
IL-9 and its receptor are predominantly involved in the pathogenesis of UCNancy Nalleweg, Mircea Teodor Chiriac, Eva Podstawa, et al.
Journal of Crohn'S & Colitis|December 26, 2025
Intestinal Barrier healing is superior to transmural healing to prevent disease progession in clinical remittent patients with IBDTill Orlemann, Dana Zimmermann, Hannah Hübner, et al.
Nature Communications|February 19, 2026
HIF sustain a transcriptional regulatory circuit of EPAS1 expression in renal clear cell carcinomaStephanie Naas, René Krüger, Steffen Grampp, et al.
The Journal of Pathology|October 1, 2003
WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancerChristoph Wissmann, Peter Johannes Wild, Simone Kaiser, et al.
Cancer Research|December 4, 2002
Frequent microsatellite instability in sporadic tumors of the upper urinary tractArndt Hartmann, Livia Zanardo, Tina Bocker-Edmonston, et al.
Pageof 94